Episurf Medical AB (publ) (EPIS-B) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.244x

Based on the latest financial reports, Episurf Medical AB (publ) (EPIS-B) has a cash flow conversion efficiency ratio of -0.244x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.60 Million ≈ $-1.25 Million USD) by net assets (Skr47.50 Million ≈ $5.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Episurf Medical AB (publ) to measure how many days the company can operate on defensive assets alone.

Episurf Medical AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Episurf Medical AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Episurf Medical AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Episurf Medical AB (publ) ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Imaspro Corporation Bhd
KLSE:7222
0.007x
Pasinex Resources Limited
F:PNX
-0.047x
Giga Media Ltd
NASDAQ:GIGM
-0.054x
Stradim Espace Finances SA
PA:ALSAS
0.150x
Crescent NV
BR:OPTI
-0.688x
Immo Moury SICAF Immobiliere Publique de Droit Belge
BR:IMMOU
0.026x
Unicasa Indústria de Móveis S.A
SA:UCAS3
0.181x
Moment Group AB
ST:MOMENT
-0.613x

Annual Cash Flow Conversion Efficiency for Episurf Medical AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Episurf Medical AB (publ) from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Episurf Medical AB (publ) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr47.50 Million
≈ $5.11 Million
Skr-55.30 Million
≈ $-5.95 Million
-1.164x -36.64%
2024-12-31 Skr83.80 Million
≈ $9.02 Million
Skr-71.40 Million
≈ $-7.68 Million
-0.852x +15.10%
2023-12-31 Skr84.50 Million
≈ $9.09 Million
Skr-84.80 Million
≈ $-9.13 Million
-1.004x -156.59%
2022-12-31 Skr177.70 Million
≈ $19.12 Million
Skr-69.50 Million
≈ $-7.48 Million
-0.391x -65.62%
2021-12-31 Skr252.80 Million
≈ $27.21 Million
Skr-59.70 Million
≈ $-6.42 Million
-0.236x +26.01%
2020-12-31 Skr169.50 Million
≈ $18.24 Million
Skr-54.10 Million
≈ $-5.82 Million
-0.319x +77.68%
2019-12-31 Skr41.40 Million
≈ $4.46 Million
Skr-59.20 Million
≈ $-6.37 Million
-1.430x -22.49%
2018-12-31 Skr44.80 Million
≈ $4.82 Million
Skr-52.30 Million
≈ $-5.63 Million
-1.167x -62.75%
2017-12-31 Skr85.57 Million
≈ $9.21 Million
Skr-61.38 Million
≈ $-6.61 Million
-0.717x +37.73%
2016-12-31 Skr48.70 Million
≈ $5.24 Million
Skr-56.10 Million
≈ $-6.04 Million
-1.152x -232.91%
2015-12-31 Skr109.93 Million
≈ $11.83 Million
Skr-38.04 Million
≈ $-4.09 Million
-0.346x +57.54%
2014-12-31 Skr38.85 Million
≈ $4.18 Million
Skr-31.66 Million
≈ $-3.41 Million
-0.815x -182.71%
2013-12-31 Skr71.61 Million
≈ $7.71 Million
Skr-20.64 Million
≈ $-2.22 Million
-0.288x +53.27%
2012-12-31 Skr24.39 Million
≈ $2.62 Million
Skr-15.05 Million
≈ $-1.62 Million
-0.617x -664.38%
2011-12-31 Skr48.50 Million
≈ $5.22 Million
Skr-3.91 Million
≈ $-421.19K
-0.081x +60.69%
2010-12-31 Skr9.74 Million
≈ $1.05 Million
Skr-2.00 Million
≈ $-215.09K
-0.205x --

About Episurf Medical AB (publ)

ST:EPIS-B Sweden Medical Devices
Market Cap
$15.46 Million
Skr143.69 Million SEK
Market Cap Rank
#25916 Global
#536 in Sweden
Share Price
Skr0.09
Change (1 day)
-6.28%
52-Week Range
Skr0.03 - Skr0.20
All Time High
Skr22.30
About

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more